Dharmaj Crop Guard Limited (DHARMAJ) reports steady revenue for Q2 & H1 FY27, despite weak monsoon affecting industry.
Sharda Cropchem Limited (SHARDACROP) reveals steady, strong, and growing trends in its October 2026 investor presentation.
Astec LifeSciences Limited (ASTEC) reports Q2 FY27 results with a revenue decline and negative EBITDA due to adverse weather and geopolitical uncertainties.
Dharmaj Crop Guard Limited reports Q1FY27 results with 5% revenue growth, EBITDA up 13%, and PAT up 17% despite challenging conditions.
Sharda Cropchem Limited (SHARDACROP) continues steady growth, showcasing strong performance and promising future in agrochemicals and industrial chemicals se.
Dharmaj Crop Guard Limited (DHARMAJ) reports Q4 FY26 results with 11% revenue growth, 57% surge in net profit.
Sharda Cropchem Limited (SHARDACROP) reports FY26 results with revenue up 22% to ₹5,268 cr, PAT more than doubling to ₹681 cr.